Stay updated on Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial

Sign up to get notified when there's something new on the Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.
    Difference
    1%
    Check dated 2025-06-19T19:43:59.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2025-06-12T15:32:27.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The page has updated its references to Biogen, indicating a shift in the ownership structure of Reata Pharmaceuticals. Additionally, several future dates have been added, while previous dates have been removed.
    Difference
    3%
    Check dated 2025-06-05T11:13:48.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    2%
    Check dated 2025-05-29T05:56:07.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2025-05-22T02:32:45.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Difference
    0.5%
    Check dated 2025-05-07T19:24:28.000Z thumbnail image

Stay in the know with updates to Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Bardoxolone Methyl in Rare Kidney Diseases Clinical Trial page.